JP Morgan Call 205 PGR 16.08.2024/ DE000JB9P610 /
14/08/2024 10:33:02 | Chg.- | Bid08:20:29 | Ask08:20:29 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.79EUR | - | 2.73 Bid Size: 250 |
- Ask Size: - |
Progressive Corporat... | 205.00 USD | 16/08/2024 | Call |
Newsfile Corp
12/08
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire
25/06
argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 P...
GlobeNewswire
24/06
Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire
24/06
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
24/06
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire
13/06
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
12/06
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
12/06
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...